4//SEC Filing
EGAN E MICHAEL 4
Accession 0001104659-03-019531
CIK 0000887137other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 4:12 PM ET
Size
25.0 KB
Accession
0001104659-03-019531
Insider Transaction Report
Form 4
DIACRIN INC /DE/DCRN
EGAN E MICHAEL
Chief Operating Officer
Transactions
- Disposition to Issuer
Employee stock option (right to buy)
2003-08-21−20,000→ 0 totalExercise: $10.75Exp: 2007-12-17→ Common Stock (20,000 underlying) - Disposition to Issuer
Employee stock option (right to buy)
2003-08-21−15,000→ 0 totalExercise: $1.25Exp: 2004-12-19→ Common Stock (15,000 underlying) - Disposition to Issuer
Employee stock option (right to buy)
2003-08-21−5,000→ 0 totalExercise: $2.50Exp: 2003-12-02→ Common Stock (5,000 underlying) - Disposition to Issuer
Employee stock option (right to buy)
2003-08-21−40,000→ 0 totalExercise: $2.08Exp: 2012-01-14→ Common Stock (40,000 underlying) - Disposition to Issuer
Employee stock option (right to buy)
2003-08-21−30,000→ 0 totalExercise: $1.40Exp: 2005-06-14→ Common Stock (30,000 underlying) - Disposition to Issuer
Common Stock
2003-08-21−66,664
Footnotes (11)
- [F1]Disposed of pursuant to a merger agreement between the issuer and GenVec, Inc. in exchange for 101,942 shares of GenVec common stock having an aggregate value of $235,486 on the effective date of the merger.
- [F10]This stock option, which is fully vested and immediately exercisable, was assumed by GenVec in connection with the merger and replaced with an option to purchase 45,876 shares of GenVec common stock at an exercise price of $0.92 per share
- [F11]This stock option, which is fully vested and immediately exercisable, was assumed by GenVec in connection with the merger and replaced with an option to purchase 30,584 shares of GenVec common stock at an exercise price of $5.40 per share.
- [F2]These stock options, which provide for vesting in four equal annual installments beginning on December 17, 1998, were assumed by GenVec in connection with the merger and replaced with an option to purchase 30,584 shares of GenVec common stock at an exercise price of $7.03 per share.
- [F3]These stock options, which provide for vesting in four equal annual installments beginning on December 21, 1999, were assumed by GenVec in connection with the merger and replaced with an option to purchase 30,584 shares of GenVec common stock at an exercise price of $3.44 per share.
- [F4]These stock options, which provide for vesting in four equal annual installments beginning on December 30, 2000, were assumed by GenVec in connection with the merger and replaced with an option to purchase 30,584 shares of GenVec common stock at an exercise price of $4.09 per share.
- [F5]These stock options, which provide for vesting in four equal annual installments beginning on December 27, 2001, were assumed by GenVec in connection with the merger and replaced with an option to purchase 30,584 shares of GenVec common stock at an exercise price of $3.07 per share.
- [F6]This stock option, which provides for vesting in four equal annual installments beginning on January 14, 2003, was assumed by GenVec in connection with the merger and replaced with an option to purchase 61,168 shares of GenVec common stock at an exercise price of $1.36 per share.
- [F7]This stock option, which provides for vesting in four equal annual installments beginning on January 13, 2004, was assumed by GenVec in connection with the merger and replaced with an option to purchase 30,584 shares of GenVec common stock at an exercise price of $0.70 per share.
- [F8]This stock option, which is fully vested and immediately exercisable, was assumed by GenVec in connection with the merger an replaced with an option to purchase 22,938 shares of GenVec common stock at an exercise price of $0.82 per share.
- [F9]This stock option, which is fully vested and immediately exercisable, was assumed by GenVec in connection with the merger and replaced with an option to purchase 7,646 share of GenVec common stock at an exercise price of $1.64 per share.
Documents
Issuer
DIACRIN INC /DE/
CIK 0000887137
Entity typeother
Related Parties
1- filerCIK 0001206268
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 4:12 PM ET
- Size
- 25.0 KB